Highly Conserved Protective Epitopes on Influenza B Viruses
Cyrille Dreyfus(Glenmark Pharmaceuticals (India)), Robert H. Friesen(Scripps Research Institute), Remko van der Vlugt(Janssen (Netherlands)), Ian A. Wilson(Raigmore Hospital), Jeong Hyun Lee(Scripps Research Institute), Miriam V. Bujny(Janssen (Netherlands)), Damian C. Ekiert(Médecins Sans Frontières), Wouter Koudstaal(Johnson & Johnson (Netherlands)), Özcan Sahin(Janssen (Netherlands)), Mohammed Lamrani(Janssen (Netherlands)), Leo L. M. Poon(Hong Kong Science and Technology Parks Corporation), N.S. Laursen(Aarhus University), Martijn Sieuwerts(Janssen (Netherlands)), Ronald Vogels(Janssen (Netherlands)), David Zuijdgeest(Janssen (Netherlands)), Mandy Jongeneelen(Janssen (Netherlands)), Eric Geelen, Hans J. W. M. Korse(Janssen (Netherlands)), Zoltan Metlagel(Lawrence Berkeley National Laboratory), Ted Kwaks(Janssen (Netherlands)), Reza Khayat(Scripps Research Institute), Andrew B. Ward(Scripps Research Institute), Jaap Goudsmit(Harvard University), Olive T. W. Li(University of Hong Kong), Just P. J. Brakenhoff(Janssen (Netherlands)), Malik Peiris(Biology of Infection)
Cited by 916
Related Papers
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia
|Nature Medicine|2006|1.9k
Influenza
|Nature Reviews Disease Primers|2018|1.5k
Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group
|Journal of Virology|2013|1.3k
Severe acute respiratory syndrome
|Nature Medicine|2004|1.2k